Alkami Technology, Inc. SEC Filings

Insider transaction summary: A Form 4 shows director Steven R. Mitchell reported an acquisition of 347 shares of Alkami Technology, Inc. (ALKT) on 10/05/2025, with an elected deferral under the 2021 Incentive Award Plan, priced at $0 to reflect the deferred issuance terms. The filing also discloses an indirect beneficial interest in 2,521,611 shares held by ARG Private Equity II, LLC (APE II), for which Mr. Mitchell serves as an adviser and disclaims beneficial ownership except for his pecuniary interest. The Form 4 was signed by an attorney-in-fact on 10/07/2025.

Insider transaction summary: A Form 4 filed for ALKAMI TECHNOLOGY, INC. (ALKT) reports that director Maria Ines Alvarez acquired 223 shares of common stock on 10/05/2025. The transaction is coded V, indicating shares issued upon vesting, and the reported price is $0, consistent with issuance of vested restricted stock rather than an open‑market purchase. After the transaction, Ms. Alvarez beneficially owns 57,623 shares. The form is signed by an attorney‑in‑fact on 10/07/2025.

Alex Shootman, Alkami Technology's Chief Executive Officer and a director, reported a sale of 42,930 shares of Alkami common stock at $25.66 per share to satisfy tax withholding obligations tied to the vesting and settlement of restricted stock units (RSUs). After the reported sale the reporting person beneficially owned 796,563 shares. The Form 4 states the transaction was a "sell to cover" to fund tax withholding and was not a discretionary sale by the reporting person.

Prerna Sachdeva, Chief Accounting Officer of Alkami Technology, Inc. (ALKT), reported a routine insider sale on a Form 4. The filing shows a disposition of 2,967 shares of Alkami common stock on 09/02/2025 at a price of $24.76 per share. The sale was executed as a "sell-to-cover" to satisfy tax withholding obligations arising from the vesting and settlement of restricted stock units. Following the transaction, the reporting person beneficially owns 66,061 shares. The Form 4 was signed by an attorney-in-fact and filed with the SEC.

Douglas A. Linebarger, Chief Legal Officer of Alkami Technology, Inc. (ALKT), reported a non-discretionary sale of 8,242 shares of common stock on 09/02/2025 at a price of $24.76 per share. The filing states the shares were sold to satisfy tax withholding obligations arising from the vesting and settlement of restricted stock units (RSUs) and were executed as a "sell to cover" rather than a voluntary trade. After the transaction the reporting person beneficially owned 229,930 shares directly. The Form 4 was signed on 09/04/2025 and was filed by one reporting person.

W. Bryan Hill, Chief Financial Officer and director of Alkami Technology, Inc. (ALKT), reported the sale of 20,366 shares of the company's common stock on 09/02/2025 at a price of $24.76 per share. The filing shows the transaction was a "sell-to-cover" to satisfy tax withholding on vested RSUs and was not a discretionary sale by the reporting person. After the transaction, the reporting person beneficially owned 409,889 shares. The Form 4 discloses standard insider reporting details and clarifies the sale's purpose as tax-related rather than an open-market liquidity decision.

Alex Shootman, Chief Executive Officer and a director of Alkami Technology, Inc. (ALKT), reported a sale of 75,000 shares of common stock on 08/27/2025, at a weighted-average price of $25.1954 per share (individual trade prices ranged from $24.84 to $25.36). After the reported sale, the reporting person beneficially owned 839,493 shares. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan, and the filer offers to provide details on the number of shares sold at each price within the reported range upon request.

General Atlantic and affiliated funds filed a Schedule 13D reporting shared beneficial ownership of 12,033,436 shares of Alkami Technology, Inc. common stock, representing 11.6% of the class based on 104,083,138 shares outstanding as of June 30, 2025. This Schedule 13D amends and supersedes a previously filed Schedule 13G/A.

The filing states the shares were acquired for investment purposes. The Reporting Persons may engage with shareholders, management or the board and may buy, sell or otherwise change their position over time. Purchases during the 60-day period before August 20, 2025 are reported in an attached Annex A. The group entered a Joint Filing Agreement and discloses shared voting and dispositive power over the reported shares.

General Atlantic-affiliated investment vehicles reported a sequence of open-market purchases of Alkami Technology (ALKT) common stock between August 11 and August 13, 2025. The group acquired a total of 1,396,162 shares across five transactions at net prices ranging from $20.647 to $22.5388. These purchases increased the reporting group's combined beneficial ownership to 12,033,436 shares.

The filings identify multiple General Atlantic entities as reporting persons, each marked as a director and a 10% owner for Section 16 purposes, and include descriptive footnotes explaining the ownership structure and group relationships. No derivative securities were reported on this Form 4.